HDAC6 functions as a tumor suppressor by activating JNK-mediated beclin 1-dependent autophagic cell death in liver cancer
Hepatology,

Jung KH et al. – The findings suggest that loss of histone deacetylase 6 (HDAC6) expression in human HCCs and tumor suppression by HDAC6 occur via the activation of caspase–independent autophagic cell death through c–Jun NH2–terminal kinase (JNK)/Beclin 1 pathway in liver cancer, and thus, that a novel tumor suppressor function mechanism involving HDAC6 may be amenable to non–epigenetic regulation.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore